AU2001288794A1 - Eiav p26 deletion vaccine and diagnostic - Google Patents

Eiav p26 deletion vaccine and diagnostic

Info

Publication number
AU2001288794A1
AU2001288794A1 AU2001288794A AU8879401A AU2001288794A1 AU 2001288794 A1 AU2001288794 A1 AU 2001288794A1 AU 2001288794 A AU2001288794 A AU 2001288794A AU 8879401 A AU8879401 A AU 8879401A AU 2001288794 A1 AU2001288794 A1 AU 2001288794A1
Authority
AU
Australia
Prior art keywords
eiav
diagnostic
deletion vaccine
vaccine
deletion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288794A
Inventor
Karen K. Brown
Jodi Craigo
Kristina J. Hennessey
Charles Issel
Ronald C. Montelaro
Bridget Puffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2001288794A1 publication Critical patent/AU2001288794A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001288794A 2000-09-09 2001-09-06 Eiav p26 deletion vaccine and diagnostic Abandoned AU2001288794A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/659,026 US6461616B1 (en) 2000-09-09 2000-09-09 EIAV p26 deletion vaccine and diagnostic
US09/659,026 2000-09-09
PCT/US2001/027600 WO2002020050A2 (en) 2000-09-09 2001-09-06 Eiav p26 deletion vaccine and diagnostic

Publications (1)

Publication Number Publication Date
AU2001288794A1 true AU2001288794A1 (en) 2002-03-22

Family

ID=24643725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288794A Abandoned AU2001288794A1 (en) 2000-09-09 2001-09-06 Eiav p26 deletion vaccine and diagnostic

Country Status (3)

Country Link
US (4) US6461616B1 (en)
AU (1) AU2001288794A1 (en)
WO (1) WO2002020050A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461616B1 (en) * 2000-09-09 2002-10-08 Akzo Nobel Nv EIAV p26 deletion vaccine and diagnostic
US20040219166A1 (en) * 2000-09-09 2004-11-04 Montelaro Ronald C. EIA vaccine and diagnostic
US6585978B1 (en) * 2000-09-09 2003-07-01 Akzo Nobel EIA vaccine and diagnostic
GB0318247D0 (en) * 2003-08-05 2003-09-10 Royal Veterinary College Antigen delivery system
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
DE102006032101A1 (en) * 2006-07-11 2008-01-24 Siemens Ag Feed unit for conveying fuel
AU2008280898B2 (en) * 2007-07-25 2013-06-27 The Kitasato Institute Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test
US11185555B2 (en) 2016-04-11 2021-11-30 Noah James Harrison Method to kill pathogenic microbes in a patient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674720A (en) * 1988-11-10 1997-10-07 United States Of America Design and construction of non-infectious human retroviral mutants deficient in genomic RNA
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
ATE429505T1 (en) * 1996-02-21 2009-05-15 Genetic Immunity Kft METHOD AND COMPOSITIONS FOR GENETIC PROTECTIVE AND THERAPEUTIC IMMUNIZATION
PT1895010E (en) * 1997-12-22 2012-01-25 Oxford Biomedica Ltd Equine infectious anaemia virus (eiav) based vectors
CN1173036C (en) * 1999-04-21 2004-10-27 卫生部艾滋病预防与控制中心 Whole-length gene sequence of donkey leucocytic hyptoxic vaccine strain for horse's infectious anemia (EIAV)
US6461616B1 (en) * 2000-09-09 2002-10-08 Akzo Nobel Nv EIAV p26 deletion vaccine and diagnostic

Also Published As

Publication number Publication date
WO2002020050A3 (en) 2003-08-28
WO2002020050A9 (en) 2003-03-27
US20030026814A1 (en) 2003-02-06
US20020155130A1 (en) 2002-10-24
US6461616B1 (en) 2002-10-08
US20030021807A1 (en) 2003-01-30
US6727078B2 (en) 2004-04-27
WO2002020050A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001253126A1 (en) (+) naloxone and epinephrine combination therapy
AU2001241963A1 (en) Improved medical procedure
AU2001271043A1 (en) Safe retained needle
AU2001268263A1 (en) Surgical cable assembly and method
AU2001287023A1 (en) Plasma-derived-fibrin-based matrices and tissue
AU2002220027A1 (en) Medical grasping device
AU4754202A (en) Instrumented cementing plug and system
EP1291377B8 (en) Silicone compound and cosmetic preparation
AU7862200A (en) Flip-wing tissue retainer
AU2001253170A1 (en) Soft tissue compression shield
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU2001280599A1 (en) Compounds and methods
AU2000238911A1 (en) Hat circulating device and method
AU2001253418A1 (en) Compounds and methods
AU2001259702A1 (en) Tissue regrafting
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001288794A1 (en) Eiav p26 deletion vaccine and diagnostic
AU2001294782A1 (en) Systems and methods for per use no-answer redial
AU2002210916A1 (en) Endoscope attachment and endoscope
AUPQ872300A0 (en) Compounds and methods
AU2001283850A1 (en) Method for protecting human skin
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002227925A1 (en) Human beta-defensin-3
AU2001270129A1 (en) Human phosphodiesterases